Discontinued — last reported Q4 '23

Other

Business Combination, Contingent Consideration, Liability, Current

Pfizer Business Combination, Contingent Consideration, Liability, Current remained flat by 0.0% to $95.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ4 2023
Metric ID: other_business_combination_contingent_consideration_liab_d9be34

Historical Data

2 periods
 Q4 '25Q1 '26
Value$95.00M$95.00M
QoQ Change—+0.0%
Range$95.00M – $95.00M

Frequently Asked Questions

What is Pfizer's business combination, contingent consideration, liability, current?
Pfizer (PFE) reported business combination, contingent consideration, liability, current of $95.00M in Q1 2026.